Trials / Withdrawn
WithdrawnNCT05374993
An Early Feasibility Evaluation of a Novel 3rdMolarTooth Bud Ablation Procedure
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- TriAgenics Inc · Industry
- Sex
- All
- Age
- 7 Years – 13 Years
- Healthy volunteers
- Accepted
Summary
This single-arm prospective study will enroll a minimum of 7 and a maximum 10 subjects between the ages of 7 and 13 years of age with radiographic evidence of mandibular 3rd molar tooth bud development without enamel formation. Each subject will undergo a 3TBA procedure for each qualifying mandibular 3rd molar tooth buds. Each subject will receive treatment for qualifying mandibular tooth buds during the same session. Subjects will be followed for a minimum of 12 weeks post treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 3TBA | Induce third molar tooth bud agenesis |
Timeline
- Start date
- 2022-11-01
- Primary completion
- 2023-07-01
- Completion
- 2023-07-01
- First posted
- 2022-05-16
- Last updated
- 2023-04-12
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05374993. Inclusion in this directory is not an endorsement.